Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Ademi LLP probes Bio-Techne's $11.3B Merck deal over shareholder fairness concerns

Market News
02 Jul 2026
GlobeNewsWire
View Source
Bearish
pluang ai news

Ademi LLP is investigating Bio-Techne's $11.3 billion acquisition by Merck, questioning if public shareholders are receiving a fair price of $73 per share. The law firm alleges possible breaches of fiduciary duty by Bio-Techne's board and highlights restrictive terms that penalize competing bids. This probe could impact shareholder rights and the transaction's progress. Investors are encouraged to join the investigation for more information at no cost.

More News (TECH)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App